Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug delivery
Pharma
Regeneron's Eylea franchise stumbles on several fronts in Q1
After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull down the drugmaker.
Fraiser Kansteiner
Apr 29, 2025 2:50pm
Neurotech nabs first nod for eye disease cell therapy implant
Mar 10, 2025 9:50am
Argenx banks on Vyvgart prefilled syringe approval in 2025: exec
Feb 19, 2025 1:36pm
Jabil acquires Pharmaceutics International to advance CDMO aims
Feb 4, 2025 3:13pm
Lyndra enlists Thermo Fisher for research, manufacturing support
Jan 15, 2025 3:36pm
ASH: Roche's subQ Lunsumio matches IV version in lymphoma
Dec 9, 2024 3:16pm
f19d.jpg?VersionId=CTXnvYG8duF5qnnevwbhhcmu488ffT6H)
